ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Insulin replicators (AKA biosimilars) and price impact!"
Episode Synopsis
Australia has two biosimilar insulins, and P2 Chat is here to help you get your head around what this means for people with diabetes. Jayne Lehmann and Kirrily Chambers chat out about insulin production, the difference between a generic, biosimilar and bio-equivalent medication, and insulin pricing around the world. (NB This Chat was recorded at the end of 2019, and with the launch of the second biosimilar in Australia, Optisulin an addendum chat has been added on to the original chat.) First published 29/4/2020
More episodes of the podcast P2 Diabetes Chat
Nothing sticks like Omnipod!
29/11/2023
WARNING: Diabetes sick days just got sicker!
18/06/2022
In God we trust